Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors

Abstract

Thus, the antimalarial compounds investigated in this study hold promise as a novel class of autophagy inhibitors for the treatment of newly diagnosed TMZ-sensitive and recurrent TMZ-resistant gliomas.